10th Annual Prevention and Therapies for Hepatitis and Chronic Liver Disease (Sept 27, 2025) - Cincinnati, OH

10th Annual Prevention and Therapies for Hepatitis and Chronic Liver Disease is organized by SC Liver Research Consortium (SCLRC), LLC and will be held on Sep 27, 2025 at Cincinnati, Ohio, United States of America.

Seminar Overview:
This seminar series will provide updates on the diagnosis and treatment of the dominant forms of viral hepatitis and explore the latest data on advancing liver disease, hepatocellular carcinoma, cholestatic liver disease, MASLD/MASH and other hepatic conditions.

Location-specific faculty experts will deliver state-of-the-art material utilizing a curriculum that features lectures, case analysis, current clinical trial outcomes and progress reports on promising prevention approaches and emerging therapies.

The seminar will concentrate on key diseases of the liver and address the latest diagnosis, treatment, and care management approaches in a setting that stresses interactive learning, audience participation, and collaborative discussion.

The program will increase the number of clinicians educated in preventing, diagnosing, treating, and/or referring liver-disease patients for more advanced care. The goal of this CME activity is to limit future cases and improve the outcomes of those already infected.

The live seminars will be delivered in a hybrid format that uses both live lectures and several web-based pre-readings and post-program modules. In this way, participants can earn 10 Category 1 CME Credits™ while spending just one day in the classroom.

The seminar is also available as a web-based, self paced Enduring Material.

PROGRAM HIGHLIGHT:
This seminar series focuses on the key challenges of: diagnosis and treatment of chronic liver disease, current and emerging pharmaceutical and surgical therapies, and the biggest highlights from EASL and AASLD

Topics to be covered include:

• Viral Hepatitis: The origins and pathways of HBV, HCV and the growing incidence of Delta Hepatitis
• Elimination approaches for HCV
• Hepatitis vaccines, prevention models and avoiding reactivation of the virus
• Ascites, Hepatorenal Syndrome and Hepatic Encephalopathy
• End-stage liver disease, cirrhosis, tumor reduction and transplant options
• The growing influence of alcohol on liver disease
• New non-invasive diagnostic test and screenings
• PBS and PSC - the latest outcomes from the ELATIVE and RESPONSE clinical studies
• Hepatocellular Carcinoma - management approaches and new immunotherapies
• Identifying and treating Steatotic Liver Disease (formerly NAFLD and NASH)
• Treating and curing liver disease in special populations
• Highlights from the latest EASL and AASLD conferences

Those who complete this activity will better identify how to screen, diagnose and treat their patients with Viral Hepatitis, Cirrhosis, Liver Cancer, Fatty Liver Disease and more.